Schwannomatosis
📧 Sign up to get email alerts when something new happens for Schwannomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing [NA]
A completed study evaluating resiliency training delivered to adults with neurofibromatosis via live videoconferencing.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis [Phase 2]
Phase 2 study update for tanezumab in moderate to severe pain due to Schwannomatosis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype [NA]
Completed clinical trial evaluating resiliency training delivered via Skype videoconferencing for patients with Neurofibromatosis types 1, 2…